SurgePoint Capital: Company Profile

Background

Overview

SurgePoint Capital is a venture capital firm established in 2024, headquartered in New York, New York. The firm specializes in early-stage investments, focusing on seed and pre-seed funding to support ambitious founders with bold visions for the future. Their mission is to redefine the founder-fund relationship by being long-term, strategic partners who are founder-friendly.

Mission and Vision

SurgePoint Capital is dedicated to empowering deeply technical founders at the seed and pre-seed stages. They aim to build sustainable, enduring companies by investing with conviction and providing support in strategy, recruiting, and fundraising.

Industry Significance

As a relatively new entrant in the venture capital landscape, SurgePoint Capital is positioning itself as a key player in supporting the next generation of visionary entrepreneurs. Their focus on early-stage, technical startups aligns with the growing demand for specialized funding in the technology sector.

Key Strategic Focus

Core Objectives

Early-Stage Investment: SurgePoint Capital aims to be the first commitment for founders at the seed or pre-seed stage, providing essential capital to kickstart innovative ventures.

Long-Term Partnership: The firm seeks to build sustainable, enduring companies by partnering with founders over the long term, focusing on strategic growth rather than immediate gains.

Founder Support: Beyond financial investment, SurgePoint Capital offers support in strategy development, recruitment, and fundraising to help startups navigate early challenges.

Areas of Specialization

SurgePoint Capital specializes in investing in deeply technical founders across various industries, with a particular emphasis on business and productivity software, biotechnology, and software development applications.

Key Technologies Utilized

While specific technologies are not detailed, SurgePoint Capital's portfolio includes companies developing advanced software solutions and innovative applications in their respective fields.

Primary Markets Targeted

The firm primarily targets the U.S. market, focusing on startups that address both domestic and global challenges through technological innovation.

Financials and Funding

Funding History

As of August 2025, SurgePoint Capital has made 15 investments in various startups, indicating a proactive approach to building a diverse portfolio.

Recent Funding Rounds

ZeroPath Corp.: In January 2025, SurgePoint Capital led a seed funding round for ZeroPath Corp., a cybersecurity firm specializing in discovering and fixing exploitable software vulnerabilities.

Notable Investors

SurgePoint Capital has co-invested alongside notable entities such as Y Combinator, Mergus Ventures, and Paul Graham, reflecting its strong network within the venture capital community.

Utilization of Capital

The capital raised is utilized to support early-stage companies in scaling their operations, developing products, and expanding market reach, with a focus on fostering long-term growth and sustainability.

Pipeline Development

Key Pipeline Candidates

Angstrom AI: Invested in September 2024, Angstrom AI is a startup in the business and productivity software sector.

Central: Also invested in September 2024, Central is a revenue-generating company in the business and productivity software industry.

Lumenary: Invested in September 2024, Lumenary is a startup focusing on business and productivity software.

Silurian AI: Invested in September 2024, Silurian AI is a startup in the business and productivity software sector.

TrueClaim: Invested in April 2024, TrueClaim is a revenue-generating company in the other healthcare technology systems industry.

Upsolve: Invested in April 2024, Upsolve is a revenue-generating company in the business and productivity software sector.

Tracecat: Invested in March 2024, Tracecat is a revenue-generating company in the business and productivity software industry.

Atopile: Invested in March 2024, Atopile is a startup in the software development applications sector.

Marr Labs: Invested in March 2024, Marr Labs is a revenue-generating company in the business and productivity software industry.

ParcelBio: Invested in March 2024, ParcelBio is a revenue-generating company in the biotechnology sector.

Stages of Development

The portfolio includes companies at various stages, from startups to revenue-generating entities, indicating SurgePoint Capital's commitment to supporting ventures through different growth phases.

Target Conditions

The firm's investments span multiple industries, including business and productivity software, healthcare technology, software development applications, and biotechnology, reflecting a broad interest in technological innovation.

Anticipated Milestones

While specific timelines are not provided, SurgePoint Capital's active investment strategy suggests a focus on achieving significant milestones in product development, market expansion, and revenue growth for its portfolio companies.

Technological Platform and Innovation

Proprietary Technologies

Specific proprietary technologies developed by SurgePoint Capital's portfolio companies are not detailed. However, the firm's investments indicate a focus on innovative solutions in software development and biotechnology.

Significant Scientific Methods

The portfolio includes companies employing advanced methodologies in artificial intelligence, machine learning, and software development, aiming to address complex challenges across various sectors.

Leadership Team

Jacob Snider, JD – Founder and Managing Partner

Jacob Snider is passionate about helping entrepreneurs build transformative technology companies through first principles thinking. He previously worked as a private funds and mergers and acquisitions attorney. He received his J.D. from Harvard Law School and holds a B.S. in Finance and B.A. in Economics from the University of Florida.

Bradley Snider – Advisor

Bradley Snider is committed to supporting emerging entrepreneurs. He is an avid problem solver who enjoys analyzing challenges that startups face. Bradley is an experienced angel investor and works as a quantitative trader. He received an A.B. in Mathematics from Princeton.

Market Insights and Competitor Analysis

The venture capital industry is highly competitive, with numerous firms vying to invest in promising startups. SurgePoint Capital differentiates itself by focusing on early-stage, technical founders and offering a founder-friendly approach. Competitors include other venture capital firms and angel investors targeting early-stage technology startups. The firm's emphasis on long-term partnerships and comprehensive support services positions it uniquely in the market.

Strategic Collaborations and Partnerships

SurgePoint Capital has co-invested with notable entities such as Y Combinator, Mergus Ventures, and Paul Graham, enhancing its network and collaborative opportunities within the venture capital ecosystem.

Operational Insights

SurgePoint Capital's strategic focus on early-stage, technical startups allows it to identify and nurture high-potential ventures. Its founder-friendly approach and comprehensive support services provide a competitive advantage in attracting and retaining promising entrepreneurs.

Strategic Opportunities and Future Directions

SurgePoint Capital is well-positioned to expand its portfolio by identifying emerging sectors within technology and healthcare. Its commitment to long-term partnerships and founder support aligns with the evolving needs of startups, positioning the firm for sustained growth and impact.